Company / Tangible Book Value per Share
ResMed Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$19.89
FY2025
5-year range
$6.61 / $19.89
FY2021-FY2025
Trend
+44.6%
vs FY2024
Sector context
#30 of 163
Health Care
What the data says
ResMed's tangible book value per share of $19.89 is higher than 82% of companies in the Health Care sector (FY2025). Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $1.51 in FY2019 to $19.89 in FY2025.
Based on SEC 10-K filings.
19.89 in FY2025 with a 5-year CAGR of +36.3%. Top quartile in the Health Care sector.
Improved from $9.29 to $19.89 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +26.7%
- 5-Year CAGR
- +36.3%
- 10-Year CAGR
- -
Sector benchmark
+9.4% above sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 44.6% year-over-year.
- Ranks #30 out of 163 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2019.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.89 | +44.6% |
| FY2024 | $13.75 | +48.1% |
| FY2023 | $9.29 | -5.0% |
| FY2022 | $9.78 | +47.9% |
| FY2021 | $6.61 | +56.5% |
| FY2020 | $4.22 | +179.3% |
| FY2019 | $1.51 | -78.3% |
| FY2018 | $6.96 | +9.4% |
| FY2017 | $6.37 | +40.7% |
| FY2016 | $4.52 | -52.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026